Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease
雷帕霉素纳米粒子增加了工程白细胞介素-2的治疗窗口，并推动抗原特异性调节性T细胞的扩增，以预防自身免疫性疾病
期刊:Journal of Autoimmunity
影响因子:7.9
doi:10.1016/j.jaut.2023.103125
Takashi Kei Kishimoto, Max Fournier, Alicia Michaud, Gina Rizzo, Christopher Roy, Teresa Capela, Natasha Nukolova, Ning Li, Liam Doyle, Fen-Ni Fu, Derek VanDyke, Peter G Traber, Jamie B Spangler, Sheldon S Leung, Petr O Ilyinskii
